CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-17 | Jackson Blair Curtis EVP, Chief Operating Officer | Other acquisition · Employee Stock Option (Right to Buy) | +2,790 | $24.59 | $69K | 142,344 |
| 2023-11-17 | Jackson Blair Curtis EVP, Chief Operating Officer | Other acquisition · Restricted Stock Unit Award | +523 | 26,690 | ||
| 2023-11-17 | Jackson Blair Curtis EVP, Chief Operating Officer | Other acquisition · Employee Stock Option (Right to Buy) | +2,741 | $26.82 | $74K | 139,803 |
| 2023-11-17 | Jackson Blair Curtis EVP, Chief Operating Officer | Other acquisition · Restricted Stock Unit Award | +685 | 34,951 | ||
| 2023-11-17 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Other acquisition · Employee Stock Option (Right to Buy) | +1,599 | $58.40 | $93K | 81,599 |
| 2023-11-17 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Other acquisition · Employee Stock Option (Right to Buy) | +1,089 | $65.94 | $72K | 55,589 |
| 2023-11-17 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Other acquisition · Employee Stock Option (Right to Buy) | +2,133 | $31.93 | $68K | 108,833 |
| 2023-11-17 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Other acquisition · Employee Stock Option (Right to Buy) | +3,376 | $20.03 | $68K | 172,232 |
| 2023-11-17 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Other acquisition · Restricted Stock Unit Award | +201 | 10,297 | ||
| 2023-11-17 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Other acquisition · Employee Stock Option (Right to Buy) | +3,929 | $19.34 | $76K | 200,413 |
| 2023-11-17 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Other acquisition · Restricted Stock Unit Award | +481 | 24,557 | ||
| 2023-11-17 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Other acquisition · Employee Stock Option (Right to Buy) | +2,790 | $24.59 | $69K | 142,344 |
| 2023-11-17 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Other acquisition · Restricted Stock Unit Award | +523 | 26,690 | ||
| 2023-11-17 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Other acquisition · Employee Stock Option (Right to Buy) | +2,412 | $26.82 | $65K | 123,027 |
| 2023-11-17 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Other acquisition · Restricted Stock Unit Award | +603 | 30,757 | ||
| 2023-11-17 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Other acquisition · Employee Stock Option (Right to Buy) | +499 | $46.24 | $23K | 25,499 |
| 2023-11-17 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Other acquisition · Employee Stock Option (Right to Buy) | +354 | $69.83 | $25K | 18,104 |
| 2023-11-17 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Other acquisition · Employee Stock Option (Right to Buy) | +719 | $31.64 | $23K | 36,719 |
| 2023-11-17 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Other acquisition · Employee Stock Option (Right to Buy) | +799 | $53.50 | $43K | 40,799 |
| 2023-11-17 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Other acquisition · Employee Stock Option (Right to Buy) | +1,089 | $65.94 | $72K | 55,589 |
Page 36 of 41 · 804 trades